search
Back to results

Improved Otologic Implants on Demand Intraoperatively With 3D CAD/CAM Autografts

Primary Purpose

Middle Ear Disease

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
3D CAD/CAM autograft prosthesis
Control device
Sponsored by
Nitinetics LLC
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional device feasibility trial for Middle Ear Disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • at least 18 years of age with middle ear disease requiring surgical ossicular reconstruction

Exclusion Criteria:

  • congenital anomalies

Sites / Locations

  • University of Florida-JacksonvilleRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Control

Investigational device

Arm Description

Subjects receive the control device.

Subject receives the 3D CAD/CAM autograft prosthesis implant.

Outcomes

Primary Outcome Measures

Cost savings
operative costs compared between treatment groups utilizing total operative time in minutes

Secondary Outcome Measures

Number of participants with treatment related adverse events as assessed by CTCAE v4.0
infectious process involving the use of a medical device
ABG
mean air-bone gap assessed and compared between treatment groups for statistical significance
Number of participants that experience device rejection
rejection of device/prosthesis

Full Information

First Posted
September 13, 2017
Last Updated
September 22, 2020
Sponsor
Nitinetics LLC
search

1. Study Identification

Unique Protocol Identification Number
NCT03297736
Brief Title
Improved Otologic Implants on Demand Intraoperatively With 3D CAD/CAM Autografts
Official Title
Improved Otologic Implants on Demand Intraoperatively With 3D CAD/CAM Autografts
Study Type
Interventional

2. Study Status

Record Verification Date
September 2020
Overall Recruitment Status
Unknown status
Study Start Date
March 1, 2016 (Actual)
Primary Completion Date
March 31, 2021 (Anticipated)
Study Completion Date
March 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Nitinetics LLC

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Prospectively analyze the use of 3D subtraction CAD/CAM in the operating room environment. Study participants, requiring middle ear surgery and ossicular reconstruction, will be implanted with one of two middle ear implants. The rationale is to complete a pilot study of the technology with a small number of designs. Each implant will be commonly used, in the public domain, and recreated by the CAD/CAM software.
Detailed Description
Conventional middle ear prosthetic prosthetics, including total ossicular replacement prostheses (TORPs) and partial ossicular replacement prostheses (PORPs) are expensive, require large inventories for otologic surgery services, and carry the risk of extrusion or rejection. Autologous bone and cartilage can be used for many of these applications, but it requires expensive operating room time for carving to the appropriate shape and size. The above considerations led to the concept of subtractive 3D CAD/CAM (computer assisted design/computer assisted manufacture) to produce accurate bone and cartilage autografts on demand in the operating room. Such a technology is hypothesized to save money by reducing operating room time, and reducing the need for expensive inventories of various shapes, sizes, and types of prosthetic devices. Since autologous materials are hypothesized to be less likely to extrude or cause other problems such as infection, this could also reduce costs.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Middle Ear Disease

7. Study Design

Primary Purpose
Device Feasibility
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
10 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
Active Comparator
Arm Description
Subjects receive the control device.
Arm Title
Investigational device
Arm Type
Experimental
Arm Description
Subject receives the 3D CAD/CAM autograft prosthesis implant.
Intervention Type
Device
Intervention Name(s)
3D CAD/CAM autograft prosthesis
Intervention Description
Surgical ossicular reconstruction with the experimental autograft prosthesis created using 3D subtraction CAD/CAM.
Intervention Type
Device
Intervention Name(s)
Control device
Intervention Description
Surgical ossicular reconstruction with the standard available middle ear prosthesis.
Primary Outcome Measure Information:
Title
Cost savings
Description
operative costs compared between treatment groups utilizing total operative time in minutes
Time Frame
perioperative
Secondary Outcome Measure Information:
Title
Number of participants with treatment related adverse events as assessed by CTCAE v4.0
Description
infectious process involving the use of a medical device
Time Frame
6 months
Title
ABG
Description
mean air-bone gap assessed and compared between treatment groups for statistical significance
Time Frame
preoperative; 6weeks, 3 months, and 6 months postoperatively.
Title
Number of participants that experience device rejection
Description
rejection of device/prosthesis
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: at least 18 years of age with middle ear disease requiring surgical ossicular reconstruction Exclusion Criteria: congenital anomalies
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Glenn Knox, M.D., J.D.
Phone
(904) 244-3498
Email
Glenn.Knox@jax.ufl.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Alisa Knox
Email
alisa102189@yahoo.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Glenn Knox, M.D., J.D.
Organizational Affiliation
Nitinetics LLC
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Florida-Jacksonville
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32209
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Glenn Knox, M.D., J.D.
Phone
904-244-3498
Email
Glenn.Knox@jax.ufl.edu

12. IPD Sharing Statement

Learn more about this trial

Improved Otologic Implants on Demand Intraoperatively With 3D CAD/CAM Autografts

We'll reach out to this number within 24 hrs